Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Kenya Medication Clinical Category Code System

Active as of 2026-06-04

Raw ttl | Download

@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:CodeSystem ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "med-clinical-category-cs"] ; # 
  fhir:language [ fhir:v "en"] ; # 
  fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem med-clinical-category-cs</b></p><a name=\"med-clinical-category-cs\"> </a><a name=\"hcmed-clinical-category-cs\"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">CHEMOTHERAPY<a name=\"med-clinical-category-cs-CHEMOTHERAPY\"> </a></td><td>Chemotherapy</td><td>Cytotoxic agent used to kill or inhibit cancer cells.</td></tr><tr><td style=\"white-space:nowrap\">IMMUNOTHERAPY<a name=\"med-clinical-category-cs-IMMUNOTHERAPY\"> </a></td><td>Immunotherapy</td><td>Agent that stimulates the immune system against cancer.</td></tr><tr><td style=\"white-space:nowrap\">TARGETED-THERAPY<a name=\"med-clinical-category-cs-TARGETED-THERAPY\"> </a></td><td>Targeted Therapy</td><td>Agent targeting specific molecular markers on cancer cells.</td></tr><tr><td style=\"white-space:nowrap\">HORMONAL-THERAPY<a name=\"med-clinical-category-cs-HORMONAL-THERAPY\"> </a></td><td>Hormonal Therapy</td><td>Agent that blocks or modifies hormone-driven tumour growth.</td></tr><tr><td style=\"white-space:nowrap\">SUPPORTIVE-CARE<a name=\"med-clinical-category-cs-SUPPORTIVE-CARE\"> </a></td><td>Supportive Care</td><td>Medication to manage side effects or improve tolerability.</td></tr><tr><td style=\"white-space:nowrap\">ANTI-EMETIC<a name=\"med-clinical-category-cs-ANTI-EMETIC\"> </a></td><td>Anti-emetic</td><td>Agent to prevent or treat nausea and vomiting.</td></tr><tr><td style=\"white-space:nowrap\">GROWTH-FACTOR<a name=\"med-clinical-category-cs-GROWTH-FACTOR\"> </a></td><td>Growth Factor</td><td>Colony-stimulating factor to support blood cell recovery.</td></tr><tr><td style=\"white-space:nowrap\">CORTICOSTEROID<a name=\"med-clinical-category-cs-CORTICOSTEROID\"> </a></td><td>Corticosteroid</td><td>Steroid given as part of or to support the oncology regimen.</td></tr><tr><td style=\"white-space:nowrap\">BISPHOSPHONATE<a name=\"med-clinical-category-cs-BISPHOSPHONATE\"> </a></td><td>Bisphosphonate</td><td>Agent for prevention or treatment of bone metastasis.</td></tr><tr><td style=\"white-space:nowrap\">ANALGESIC<a name=\"med-clinical-category-cs-ANALGESIC\"> </a></td><td>Analgesic</td><td>Pain management medication in the cancer care context.</td></tr></table></div>"^^rdf:XMLLiteral ]
  ] ; # 
  fhir:url [
fhir:v "https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs"^^xsd:anyURI ;
fhir:l <https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs>
  ] ; # 
  fhir:version [ fhir:v "0.1.0"] ; # 
  fhir:name [ fhir:v "MedClinicalCategoryCS"] ; # 
  fhir:title [ fhir:v "Kenya Medication Clinical Category Code System"] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:experimental [ fhir:v false] ; # 
  fhir:date [ fhir:v "2026-06-04T14:49:30+00:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "Digital Health Agency (DHA), Kenya"] ; # 
  fhir:contact ( [
fhir:name [ fhir:v "Digital Health Agency (DHA), Kenya" ] ;
    ( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://dha.go.ke" ]     ] [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "info@dha.go.ke" ]     ] )
  ] [
fhir:name [ fhir:v "Digital Health Agency Kenya – FHIR Team" ] ;
    ( fhir:telecom [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "info@dha.go.ke" ] ;
fhir:use [ fhir:v "work" ]     ] [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://dha.go.ke" ] ;
fhir:use [ fhir:v "work" ]     ] )
  ] ) ; # 
  fhir:description [ fhir:v "Codes classifying the clinical role of a medication within an oncology regimen."] ; # 
  fhir:jurisdiction ( [
    ( fhir:coding [
fhir:system [
fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ;
fhir:l <urn:iso:std:iso:3166>       ] ;
fhir:code [ fhir:v "KE" ] ;
fhir:display [ fhir:v "Kenya" ]     ] )
  ] ) ; # 
  fhir:caseSensitive [ fhir:v true] ; # 
  fhir:content [ fhir:v "complete"] ; # 
  fhir:count [ fhir:v "10"^^xsd:nonNegativeInteger] ; # 
  fhir:concept ( [
fhir:code [ fhir:v "CHEMOTHERAPY" ] ;
fhir:display [ fhir:v "Chemotherapy" ] ;
fhir:definition [ fhir:v "Cytotoxic agent used to kill or inhibit cancer cells." ]
  ] [
fhir:code [ fhir:v "IMMUNOTHERAPY" ] ;
fhir:display [ fhir:v "Immunotherapy" ] ;
fhir:definition [ fhir:v "Agent that stimulates the immune system against cancer." ]
  ] [
fhir:code [ fhir:v "TARGETED-THERAPY" ] ;
fhir:display [ fhir:v "Targeted Therapy" ] ;
fhir:definition [ fhir:v "Agent targeting specific molecular markers on cancer cells." ]
  ] [
fhir:code [ fhir:v "HORMONAL-THERAPY" ] ;
fhir:display [ fhir:v "Hormonal Therapy" ] ;
fhir:definition [ fhir:v "Agent that blocks or modifies hormone-driven tumour growth." ]
  ] [
fhir:code [ fhir:v "SUPPORTIVE-CARE" ] ;
fhir:display [ fhir:v "Supportive Care" ] ;
fhir:definition [ fhir:v "Medication to manage side effects or improve tolerability." ]
  ] [
fhir:code [ fhir:v "ANTI-EMETIC" ] ;
fhir:display [ fhir:v "Anti-emetic" ] ;
fhir:definition [ fhir:v "Agent to prevent or treat nausea and vomiting." ]
  ] [
fhir:code [ fhir:v "GROWTH-FACTOR" ] ;
fhir:display [ fhir:v "Growth Factor" ] ;
fhir:definition [ fhir:v "Colony-stimulating factor to support blood cell recovery." ]
  ] [
fhir:code [ fhir:v "CORTICOSTEROID" ] ;
fhir:display [ fhir:v "Corticosteroid" ] ;
fhir:definition [ fhir:v "Steroid given as part of or to support the oncology regimen." ]
  ] [
fhir:code [ fhir:v "BISPHOSPHONATE" ] ;
fhir:display [ fhir:v "Bisphosphonate" ] ;
fhir:definition [ fhir:v "Agent for prevention or treatment of bone metastasis." ]
  ] [
fhir:code [ fhir:v "ANALGESIC" ] ;
fhir:display [ fhir:v "Analgesic" ] ;
fhir:definition [ fhir:v "Pain management medication in the cancer care context." ]
  ] ) . #